Possible new approach to immune-resistant cancer cells


Immunotherapy stimulates the patient's immune system to fight cancer. Despite promising results, however, tumor cells are not always sensitive to this treatment. Researchers at the Netherlands Cancer Institute under the supervision of Prof. Daniel Peeper have identified a number of genes in tumor cells that are involved in therapy resistance, using CRISPR/Cas9 technology. By inactivating these genes, the cancer cells can be made much more sensitive to immunotherapy.

An article about this was on July 11 in the renowned scientific journal Cell.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.